Total planned funding: $479,402,116
Clear active filters
Own Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Ethiopia | $48,393,785 |
| South Africa | $43,189,213 |
| Uganda | $42,703,257 |
| Tanzania | $37,842,132 |
| Kenya | $36,741,558 |
| Nigeria | $36,328,992 |
| Mozambique | $34,123,191 |
| Zambia | $33,685,959 |
| Côte d'Ivoire | $22,495,118 |
| Botswana | $20,840,779 |
| Rwanda | $19,131,218 |
| Namibia | $15,958,878 |
| Vietnam | $15,673,813 |
| Haiti | $10,659,343 |
| Malawi | $7,473,550 |
| Zimbabwe | $7,329,167 |
| Caribbean Region | $6,952,463 |
| Guyana | $6,129,101 |
| India | $5,603,816 |
| Democratic Republic of the Congo | $3,984,794 |
| Cambodia | $3,632,494 |
| Thailand | $3,218,179 |
| Eswatini | $3,004,927 |
| South Sudan | $2,607,869 |
| Dominican Republic | $2,602,450 |
| Angola | $2,408,360 |
| Lesotho | $2,078,710 |
| Russia | $1,453,000 |
| Ghana | $1,270,000 |
| China | $852,000 |
| Ukraine | $534,000 |
| Indonesia | $500,000 |
Organizational Types
| Own Agency | $479,402,116 |
Program Areas
| Management and Operations | $263,656,732 |
| Governance and Systems | $56,455,171 |
| Prevention | $38,379,084 |
| Care | $22,776,392 |
| Treatment | $13,369,242 |
| Testing | $4,701,849 |
Budget Codes
| HVMS: Management and Operations | $263,656,732 |
| HVSI: Strategic Information | $27,751,499 |
| HLAB: Laboratory Infrastructure | $15,739,528 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $15,508,764 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $14,962,075 |
| OHSS: Health Systems Strengthening | $12,964,144 |
| HTXS: Treatment: Adult Treatment | $11,361,306 |
| HBHC: Care: Adult Care and Support | $8,320,594 |
| HKID: Care: Orphans and Vulnerable Children | $7,385,262 |
| HVTB: Care: TB/HIV | $7,070,536 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $6,790,252 |
| HVCT: Testing: HIV Testing and Counseling | $4,701,849 |
| HTXD: Treatment: ARV Drugs | $2,007,936 |
| HMBL: Biomedical Prevention: Blood Safety | $711,112 |
| HMIN: Biomedical Prevention: Injection Safety | $406,881 |